Physician profile
Michael W Bratton
NPI 1578514451
$1,302.00
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $270 · 2021: $327 · 2022: $195 · 2023: $79.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $475.27 | 2019-2021 | |
| Amgen INC. | $170.52 | 2020-2022 | |
| Alpha Orthopedic Systems | $130.50 | 2019 | |
| Sanofi-Aventis U.S. LLC | $100.72 | 2019-2023 | |
| Convatec INC. | $77.26 | 2019-2023 | |
| Stryker Corporation | $65.45 | 2019-2022 | |
| Zyla Life Sciences, INC. | $43.76 | 2019 | |
| Depuy Synthes Sales INC. | $43.23 | 2022 | |
| Fidia Pharma USA INC. | $39.63 | 2022-2023 | Hymovis, Triluron |
| Bioventus LLC | $31.73 | 2019-2021 | |
| Heron Therapeutics, INC. | $30.00 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $27.03 | 2022 | |
| Medartis INC. | $20.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.80 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.37 | 2023 | Seglentis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kinex Medical Company LLC | $9.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bratton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.